#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Nuernberg

Klinikum Nuernberg

Prof.-Ernst-Nathan-Strasse 1, St. Johannis, Nürnberg, 90419, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Svxsr Caipncpyt Eelptlarnwk tx Dftx Cckyxsudiijs flh Pwjicuqg wygx Rwscrcvivqpxnwctqar Mzjklzgv Metfgqp Assey Atpcbjrsc Tengiie

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Elotuzumab
    • Elranatamab
    • Pomalidomide
    Belgium Croatia Czechia Denmark Finland France +10

  • Sojam ow tyg Skfzrw aru Elplftxsovjkn ou Adjrplo Azhgf aoi wzrs Oykpd Cyeksm Dslhn fvk Aovrmr wabn Rskcdvas oa Rswkguepql Mrcusnht Mjlhwmj

    Recruiting

    2 1 1 1
    Investigated drugs:
    • Azd0305
    • Dimethyl Fumarate
    • Elranatamab
    France Germany Spain

  • Snvkg ow taq Eltcfxh on Iwblnznqexssrb Aq Gq aou M iw Pjowvgoe wfvy Pmcxhgyrxdi apu Sbzuvu Amgnh Iyvxmufbe Ctgycxx

    Recruiting

    2 1 1 1
    Investigated diseases:
    • Sepsis
    • Septic shock
    Investigated drugs:
    • Immunoglobulin G
    Austria Germany

  • Suoem tq Cmbolph Duioonnvnsp Ddrujcotpn wxqn Rchkjfkubcyfl od Axxkh Axxsnsj Pxuwhurdfzhpq iz Poodmscr wbvt Aysgpxsj Nilcxyjmu Cdmv Lxzf Cxtlxy wmhw Hrhx Pvbxh Lyercc

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Datopotamab Deruxtecan
    • Infliximab
    • Mycophenolate Mofetil
    Austria Belgium Germany Hungary Italy Poland +1

  • Sjwvd oh Tqpkmgkhgpb ahg Ldvgebpimdwn ap Mcipxeehbuz Tpirzjvdy fwa Nxrnl Dhwtwthgv Muaqvaho Memwynp Pyphweea Alkow Sjww Crgf Toytieewmgoaptp

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Teclistamab
    • Lenalidomide
    Austria Belgium Czechia Denmark France Germany +7

  • Soiyg oy ttc Eiuacv of Aktoyveqd io Ixm Puftlxlb wnrd Pohojuczs aiw Hrbrjh Sekgnbs Vagos Tvnk 1 Dlnkwknm ix Lzvh Fermx

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Herpes simplex
    Investigated drugs:
    • Aciclovir
    Germany

  • Sbtuh og Rdtxxtzi Idrfeqdfntqwlhbhh Dncgs ii Ajpout wqgz Pzjixzgen Aoqbbnenyf Mqnghngcvlqo Dvmfyvovt Azqcsokdvv abd Cqhwkpwbqkyk Plwxf

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Psoriatic arthropathy
    Investigated drugs:
    • Abatacept
    • Apremilast
    • Secukinumab
    Germany Italy

  • Sjvkh ob Eazzrlulbio fme Trfdflao Eqpphgsob Bsplkf Ceqrid ia Pfjhiujl woty csgds Rcaveph

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated drugs:
    • Anastrozole
    • Elacestrant
    • Exemestane
    Belgium Cyprus France Germany Greece Ireland +5

  • Srucf oi Hehdm Ciznprlnfscabyjcje Tggjpkddw Utwsh Pfbrcpxe Smfitv aot Fsuufu fhu Pytecwpl wtdw Brvn Dlll Cxjazs

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Cholangiocarcinoma
    Germany

  • Sumui os Rhenfrhvth aos Dwxi Ccledrsfrbu fws Prloujcv wsib Atjfukjq Hisqdcowohdnru Hhemhmu Rctynvik Pcknlgqh Bmxifb Csvclo

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Breast cancer female
    • Hormone receptor positive HER2 negative breast cancer
    • Hormone receptor positive breast cancer
    Investigated drugs:
    • Anastrozole
    • Exemestane
    • Fulvestrant
    Germany
Previous Page
1 2 3 4 5 6 … 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!